Retatrutide is a new medication in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in investigations. By boosting these receptors, https://esmeecjyu235185.targetblogs.com/36701744/retatrutide-a-promising-new-treatment-for-obesity